Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
University of Michigan–Ann Arbor · Michigan Center for Translational Pathology · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
949
total citations
- FWCI
- 41.54
- Percentile
- 100%
- References
- 42
Citations per year
Authors
18- IAIrfan A. AsanganiCorresponding
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- VLVijaya L. Dommeti
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- XWXiaoju Wang
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- RMRohit Malik
Michigan Center for Translational Pathology, University of Michigan–Ann Arbor
- MCMarcin Cieślik
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
Topics & keywords
Topics
Keywords
- Bromodomain
- BRD4
- Enzalutamide
- Prostate cancer
- BET inhibitor
- Androgen receptor
- Cancer research
- Epigenetics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.